Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ANTIPHOSPHOLIPID SYNDROME AS A MODIFIER OF CLINICAL PHENOTYPES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A CASE-CONTROL STUDY.

Georgian medical news - 1 Mar 2026

Archaia N, Chumburidze V, Kakauridze N

Abstract excerpt

BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disorder characterized by persistent antiphospholipid antibodies and vascular thrombosis. Its contribution to clinical phenotypes of atherosclerotic cardiovascular disease (ASCVD) remains incompletely defined. OBJECTIVE: To evaluate the association between APS and clinical, thrombotic, and laboratory characteristics in patients with ASCVD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anticardiolipin
Share to Antibodies, Antiphospholipid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiphospholipid Syndrome

Share to Atherosclerosis

Share to beta 2-Glycoprotein I

Share to Case-Control Studies

Share to Lupus Coagulation Inhibitor

Share to Thrombosis

Source

Identifiers

PMID: 42107957

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ANTIPHOSPHOLIPID SYNDROME AS A MODIFIER OF CLINICAL PHENOTYPES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A CASE-CONTROL STUDY.PMID 42107957Read ↗

Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.Semantic proximity Read ↗

Genetic determinants of arterial thrombosis in primary antiphospholipid syndrome: a systematic review.Semantic proximity Read ↗

Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine.Semantic proximity Read ↗

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics ApproachesSemantic proximity Read ↗

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?Semantic proximity Read ↗

What is antiphospholipid syndrome?Semantic proximity Read ↗

From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.Semantic proximity Read ↗

Vascular Thrombosis in COVID-19: A Potential Association with Antiphospholipid AntibodiesSemantic proximity Read ↗

Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping reviewSemantic proximity Read ↗

Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.Semantic proximity Read ↗

LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.Semantic proximity Read ↗

[Antiphospholipid syndrome: pathophysiology and clinicobiological aspects].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.